-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) Sees Large Decline in Short Interest
Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) Sees Large Decline in Short Interest
Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA – Get Rating) was the target of a large drop in short interest during the month of December. As of December 30th, there was short interest totalling 174,600 shares, a drop of 11.6% from the December 15th total of 197,600 shares. Based on an average daily volume of 77,200 shares, the short-interest ratio is presently 2.3 days. Currently, 1.8% of the company's shares are short sold.
Comera Life Sciences Price Performance
CMRA stock traded down $0.07 during midday trading on Friday, hitting $1.40. The stock had a trading volume of 59,692 shares, compared to its average volume of 171,715. The business has a fifty day moving average price of $1.39 and a two-hundred day moving average price of $1.87. Comera Life Sciences has a 1-year low of $1.11 and a 1-year high of $11.44.
Get Comera Life Sciences alerts:Comera Life Sciences (NASDAQ:CMRA – Get Rating) last released its earnings results on Thursday, November 10th. The company reported ($0.20) EPS for the quarter. The company had revenue of $0.24 million during the quarter.
Insider Buying and Selling
In related news, major shareholder David Soane purchased 202,701 shares of the firm's stock in a transaction dated Wednesday, January 4th. The stock was bought at an average price of $1.23 per share, with a total value of $249,322.23. Following the completion of the purchase, the insider now owns 3,336,562 shares in the company, valued at approximately $4,103,971.26. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. 4.50% of the stock is owned by corporate insiders.Institutional Trading of Comera Life Sciences
Several hedge funds have recently modified their holdings of the stock. Bluefin Capital Management LLC bought a new stake in Comera Life Sciences in the second quarter valued at $73,000. Jane Street Group LLC acquired a new position in Comera Life Sciences during the 2nd quarter worth approximately $115,000. Arena Investors LP acquired a new stake in Comera Life Sciences in the third quarter valued at approximately $137,000. Virtu Financial LLC bought a new stake in shares of Comera Life Sciences during the third quarter valued at approximately $25,000. Finally, Lake Street Advisors Group LLC raised its position in shares of Comera Life Sciences by 216.5% during the third quarter. Lake Street Advisors Group LLC now owns 316,469 shares of the company's stock worth $510,000 after purchasing an additional 216,469 shares during the period. Institutional investors own 2.94% of the company's stock.
Comera Life Sciences Company Profile
(Get Rating)
Comera Life Sciences Holdings, Inc, a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions.
Read More
- Get a free copy of the StockNews.com research report on Comera Life Sciences (CMRA)
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving '23 Growth
Receive News & Ratings for Comera Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Comera Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA – Get Rating) was the target of a large drop in short interest during the month of December. As of December 30th, there was short interest totalling 174,600 shares, a drop of 11.6% from the December 15th total of 197,600 shares. Based on an average daily volume of 77,200 shares, the short-interest ratio is presently 2.3 days. Currently, 1.8% of the company's shares are short sold.
Comera Life Sciences Holdings, Inc.（纳斯达克股票代码：CMRA — Get Ratings）是12月空头利率大幅下降的目标。截至12月30日，空头利率共计17.46万股，较12月15日的197,600股下降了11.6％。根据77,200股的平均每日成交量，目前的空头利率为2.3天。目前，该公司1.8％的股票被卖空。
Comera Life Sciences Price Performance
Comera 生命科学价格表现
CMRA stock traded down $0.07 during midday trading on Friday, hitting $1.40. The stock had a trading volume of 59,692 shares, compared to its average volume of 171,715. The business has a fifty day moving average price of $1.39 and a two-hundred day moving average price of $1.87. Comera Life Sciences has a 1-year low of $1.11 and a 1-year high of $11.44.
CMRA股票在周五午盘交易中下跌0.07美元，至1.40美元。该股的交易量为59,692股，而平均交易量为171,715股。该公司的五十天移动平均价格为1.39美元，两百天移动平均线价格为1.87美元。Comera Life Sciences创下1年低点1.11美元，1年高点为11.44美元。
Comera Life Sciences (NASDAQ:CMRA – Get Rating) last released its earnings results on Thursday, November 10th. The company reported ($0.20) EPS for the quarter. The company had revenue of $0.24 million during the quarter.
Comera Life Sciences（纳斯达克股票代码：CMRA — Get Rating）上次发布财报是在11月10日星期四。该公司报告了本季度每股收益（0.20 美元）。该公司在本季度的收入为24万美元。
Insider Buying and Selling
内幕买入和卖出
Institutional Trading of Comera Life Sciences
Comera 生命科学的机构交易
Several hedge funds have recently modified their holdings of the stock. Bluefin Capital Management LLC bought a new stake in Comera Life Sciences in the second quarter valued at $73,000. Jane Street Group LLC acquired a new position in Comera Life Sciences during the 2nd quarter worth approximately $115,000. Arena Investors LP acquired a new stake in Comera Life Sciences in the third quarter valued at approximately $137,000. Virtu Financial LLC bought a new stake in shares of Comera Life Sciences during the third quarter valued at approximately $25,000. Finally, Lake Street Advisors Group LLC raised its position in shares of Comera Life Sciences by 216.5% during the third quarter. Lake Street Advisors Group LLC now owns 316,469 shares of the company's stock worth $510,000 after purchasing an additional 216,469 shares during the period. Institutional investors own 2.94% of the company's stock.
几家对冲基金最近修改了持有的该股。Bluefin Capital Management LLC在第二季度收购了价值73,000美元的新股份。Jane Street Group LLC在第二季度收购了Comera Life Sciences的新职位，价值约11.5万美元。Arena Investors LP在第三季度收购了Comera Life Sciences的新股份，价值约13.7万美元。Virtu Financial LLC在第三季度购买了Comera Life Sciences股票的新股份，价值约为25,000美元。最后，Lake Street Advisors Group LLC在第三季度将其在Comera Life Sciences的股票头寸提高了216.5％Lake Street Advisors Group LLC在此期间又购买了216,469股股票后，现在拥有该公司316,469股股票，价值51万美元。机构投资者拥有该公司2.94％的股票。
Comera Life Sciences Company Profile
Comera 生命科学公司简介
(Get Rating)
（获取评分）
Comera Life Sciences Holdings, Inc, a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions.
Comera Life Sciences Holdings, Inc是一家临床前阶段的生命科学公司，该公司开发了内部专有疗法产品组合，其中包括其专有配方平台SqorE。其SqorE平台旨在实现静脉注射（IV）生物制剂转换为皮下（SQ）版本。
Read More
阅读更多
- Get a free copy of the StockNews.com research report on Comera Life Sciences (CMRA)
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving '23 Growth
- 免费获取 StockNews.com 关于 Comera Life Sciences（CMRA）的研究报告
- MarketBeat Week 回顾 — 1/16 — 1/20
- Old Dominion 是否表明卡车运输正在刹车？
- 诺德斯特龙将对降价的恐惧带入零售业
- 埃克森美孚股票：距离买入点仅几步之遥
- 高股息收益的必和必拓认为中国将推动 “23” 的增长
Receive News & Ratings for Comera Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Comera Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
接收《Comera生命科学日报》的新闻和评级 -在下面输入您的电子邮件地址，通过Marketbeat.com的免费每日电子邮件时事通讯接收Comera Life Sciences及相关公司的最新新闻和分析师评级的简明每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧